| FDG-PET/CT and MRI for evaluation of pathologic response to neoadjuvant chemotherapy in patients with breast cancer: a meta-analysis of diagnostic accuracy studies S Sheikhbahaei, TJ Trahan, J Xiao, M Taghipour, E Mena, RM Connolly, ... The oncologist 21 (8), 931-939, 2016 | 193 | 2016 |
| Diagnostic accuracy of follow-up FDG PET or PET/CT in patients with head and neck cancer after definitive treatment: a systematic review and meta-analysis S Sheikhbahaei, M Taghipour, R Ahmad, C Fakhry, AP Kiess, CH Chung, ... American Journal of Roentgenology 205 (3), 629-639, 2015 | 105 | 2015 |
| Classification of clinical significance of MRI prostate findings using 3D convolutional neural networks A Mehrtash, A Sedghi, M Ghafoorian, M Taghipour, CM Tempany, ... Medical imaging 2017: computer-aided diagnosis 10134, 589-592, 2017 | 95 | 2017 |
| Reliability of different RBC indices and formulas in discriminating between β-thalassemia minor and other microcytic hypochromic cases E Bordbar, M Taghipour, BE Zucconi Mediterranean journal of hematology and infectious diseases 7 (1), 2015 | 70 | 2015 |
| 18F-FDG PET/CT: therapy response assessment interpretation (Hopkins criteria) and survival outcomes in lung cancer patients S Sheikhbahaei, E Mena, C Marcus, R Wray, M Taghipour, ... Journal of Nuclear Medicine 57 (6), 855-860, 2016 | 52 | 2016 |
| Value of intratumoral metabolic heterogeneity and quantitative 18F-FDG PET/CT parameters to predict prognosis in patients with HPV-positive primary oropharyngeal squamous cell … E Mena, M Taghipour, S Sheikhbahaei, AK Jha, A Rahmim, L Solnes, ... Clinical nuclear medicine 42 (5), e227-e234, 2017 | 43 | 2017 |
| Investigating the role of DCE-MRI, over T2 and DWI, in accurate PI-RADS v2 assessment of clinically significant peripheral zone prostate lesions as defined at radical prostatectomy M Taghipour, A Ziaei, F Alessandrino, E Hassanzadeh, M Harisinghani, ... Abdominal radiology 44, 1520-1527, 2019 | 38 | 2019 |
| FDG PET/CT in pancreatic and hepatobiliary carcinomas: value to patient management and patient outcomes U Parikh, C Marcus, R Sarangi, M Taghipour, RM Subramaniam PET clinics 10 (3), 327-343, 2015 | 38 | 2015 |
| Value of FDG PET/CT in patient management and outcome of skeletal and soft tissue sarcomas S Sheikhbahaei, C Marcus, N Hafezi-Nejad, M Taghipour, ... PET clinics 10 (3), 375-393, 2015 | 35 | 2015 |
| Predictive role of PI-RADSv2 and ADC parameters in differentiating Gleason pattern 3+ 4 and 4+ 3 prostate cancer F Alessandrino, M Taghipour, E Hassanzadeh, A Ziaei, M Vangel, ... Abdominal Radiology 44, 279-285, 2019 | 32 | 2019 |
| Use of 18F-fludeoxyglucose–positron emission tomography/computed tomography for patient management and outcome in oropharyngeal squamous cell carcinoma: a review M Taghipour, S Sheikhbahaei, W Marashdeh, L Solnes, A Kiess, ... JAMA Otolaryngology–Head & Neck Surgery 142 (1), 79-85, 2016 | 30 | 2016 |
| 18F-FDG PET/CT Metabolic Tumor Volume and Intratumoral Heterogeneity in Pancreatic Adenocarcinomas: Impact of Dual–Time Point and Segmentation Methods E Mena, S Sheikhbahaei, M Taghipour, AK Jha, E Vicente, J Xiao, ... Clinical nuclear medicine 42 (1), e16-e21, 2017 | 26 | 2017 |
| 18F-FDG-PET/CT therapy assessment of locally advanced pancreatic adenocarcinoma: impact on management and utilization of quantitative parameters for patient survival prediction S Sheikhbahaei, R Wray, B Young, E Mena, M Taghipour, A Rahmim, ... Nuclear medicine communications 37 (3), 231-238, 2016 | 23 | 2016 |
| Serum levels of G-CSF and IL-7 in Iranian breast cancer patients E Bordbar, M Malekzadeh, MTF Ardekani, M Doroudchi, A Ghaderi Asian Pacific Journal of Cancer Prevention 13 (10), 5307-5312, 2012 | 22 | 2012 |
| Value of Fluorodeoxyglucose PET/Computed Tomography Patient Management and Outcomes in Thyroid Cancer C Anthony, M Charles, T Mehdi, MS Rathan PET Clinics, 2015 | 20 | 2015 |
| FDG PET/CT in patients with head and neck squamous cell carcinoma after primary surgical resection with or without chemoradiation therapy M Taghipour, S Sheikhbahaei, R Wray, N Agrawal, J Richmon, H Kang, ... American Journal of Roentgenology 206 (5), 1093-1100, 2016 | 19 | 2016 |
| FDG avidity and tumor burden: survival outcomes for patients with recurrent breast cancer M Taghipour, R Wray, S Sheikhbahaei, JL Wright, RM Subramaniam American Journal of Roentgenology 206 (4), 846-855, 2016 | 18 | 2016 |
| The value of follow‐up FDG‐PET/CT in the management and prognosis of patients with HPV‐positive oropharyngeal squamous cell carcinoma M Taghipour, C Marcus, J Califano, C Fakhry, RM Subramaniam Journal of Medical Imaging and Radiation Oncology 59 (6), 681-686, 2015 | 18 | 2015 |
| 18F-FDG PET/CT and colorectal cancer: value of fourth and subsequent posttherapy follow-up scans for patient management C Marcus, W Marashdeh, SJ Ahn, M Taghipour, RM Subramaniam Journal of Nuclear Medicine 56 (7), 989-994, 2015 | 18 | 2015 |
| Evaluation of pre-treatment serum levels of IL-7 and GM-CSF in colorectal cancer patients MTF Ardekani, M Malekzadeh, SV Hosseini, E Bordbar, M Doroudchi, ... International journal of molecular and cellular medicine 3 (1), 27, 2014 | 18 | 2014 |
Rathan SubramaniamUniversity of Notre Dame Australia, Sydney, AustraliaVerified email at nd.edu.au
